Search research articles

ABOUT JoVE

Overview Leadership Blog JoVE Help Center

AUTHORS

Publishing Process Editorial Board Scope & Policies Peer Review FAQ Submit

LIBRARIANS

Testimonials Subscriptions Access Resources Library Advisory Board FAQ

RESEARCH

JoVE Journal Methods Collections JoVE Encyclopedia of Experiments Archive

EDUCATION

JoVE Core JoVE Business JoVE Science Education JoVE Lab Manual Faculty Resource Center Faculty Site

Terms & Conditions of Use

Yanping Wang

5PUBLICATIONS

27CO-AUTHORS

Molecular targets

Featured researcher

Get your video featured.

Publish with JoVE

Featured researcher

Get your video featured.

Publish with JoVE

Publications (5)

Sort by Publication Date:

|May 07, 2025

JAB-3312, a Potent Allosteric SHP2 Inhibitor That Enhances the Efficacy of RTK/RAS/MAPK and PD-1 Blockade Therapies.

Di Kang, Yanping Wang, Yiwei Lin

|Apr 30, 2025

Glecirasib, a Potent and Selective Covalent KRAS G12C Inhibitor Exhibiting Synergism with Cetuximab or SHP2 Inhibitor JAB-3312.

Peng Wang, Xin Sun, Xueting He

|Jan 28, 2025

Design, Structure Optimization, and Preclinical Characterization of JAB-21822, a Covalent Inhibitor of KRAS<sup>G12C</sup>.

Amin Li, Sujing Li, Peng Wang

|Aug 07, 2024

Discovery of JAB-3312, a Potent SHP2 Allosteric Inhibitor for Cancer Treatment.

Cunbo Ma, Di Kang, Panliang Gao

|May 20, 2024

Preclinical Evaluation of JAB-2485, a Potent AURKA Inhibitor with High Selectivity and Favorable Pharmacokinetic Properties.

Guiqun Yang, Yiwei Lin, Xin Sun

Pageof 1

Frequent Collaborators

4 joint publications

Yinxiang Wang

3 joint publications

Di Kang

2 joint publications

Cunbo Ma

2 joint publications

Yiwei Lin

2 joint publications

Wei Zhang

2 joint publications

Xin Sun

2 joint publications

Peng Wang

2 joint publications

Amin Li

1 joint publications

Xinping Wu

1 joint publications

Zilong Xu

Frequent Collaborators

4 joint publications

Yinxiang Wang

3 joint publications

Di Kang

2 joint publications

Cunbo Ma

2 joint publications

Yiwei Lin

Top Related Videos

Assessing Cellular Target Engagement by SHP2 (PTPN11) Phosphatase Inhibitors

Assessing Cellular Target Engagement by SHP2 (PTPN11) Phosphatase Inhibitors

Published on : Jul 17, 2020

A Rapid Screening Workflow to Identify Potential Combination Therapy for GBM using Patient-Derived Glioma Stem Cells

A Rapid Screening Workflow to Identify Potential Combination Therapy for GBM using Patient-Derived Glioma Stem Cells

Published on : Mar 28, 2021

Development and Maintenance of a Preclinical Patient Derived Tumor Xenograft Model for the Investigation of Novel Anti-Cancer Therapies

Development and Maintenance of a Preclinical Patient Derived Tumor Xenograft Model for the Investigation of Novel Anti-Cancer Therapies

Published on : Sep 30, 2016

See more related videos

Top Related Videos

Assessing Cellular Target Engagement by SHP2 (PTPN11) Phosphatase Inhibitors

Assessing Cellular Target Engagement by SHP2 (PTPN11) Phosphatase Inhibitors

Published on : Jul 17, 2020

A Rapid Screening Workflow to Identify Potential Combination Therapy for GBM using Patient-Derived Glioma Stem Cells

A Rapid Screening Workflow to Identify Potential Combination Therapy for GBM using Patient-Derived Glioma Stem Cells

Published on : Mar 28, 2021

Development and Maintenance of a Preclinical Patient Derived Tumor Xenograft Model for the Investigation of Novel Anti-Cancer Therapies

Development and Maintenance of a Preclinical Patient Derived Tumor Xenograft Model for the Investigation of Novel Anti-Cancer Therapies

Published on : Sep 30, 2016

See more related videos